JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
JW (Cayman) Therapeutics Co. Ltd has announced the composition of its board of directors and the allocation of roles within four Board committees. The Board includes executive and non-executive members, with Dr. Yiping James Li serving as the Chairman. Key committee roles are held by members with specific oversight responsibilities, ensuring governance and strategic direction for the company.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
